Tuesday, April 29, 2025
Home 2021

Yearly Archives: 2021

CoronaVirus

Up 2,950% is Novavax (NVAX) Still a Buy?

Editor / Curator -
Featured

Alkaline Water Co., (WTER) Announces 33rd Straight Up Quarter.

Editor / Curator -
Biotech News

Resuming Coverage on PetVivo (PETV).

Editor / Curator -
Bitcoin

How to Find 100x Crypto Gems Before Anyone Else (Comtex).

Editor / Curator -
Biotech Stock Review
2021 Watch List

Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top...

Editor / Curator -
ehave,
Telehealth

Telehealth: Contactless Health Screening from Ehave (EHVVF) and VastMinz.

Editor / Curator -
Drone Stock Review. Draganfly
Drones

Draganfly (DPRO) Shareholder Call Today, 4PM EST.

Editor / Curator -
Biotech Stock Review, DYAI
2020 Watch List

Dyadic (DYAI) Scores $10M deal with Sorrento Therapeutics (SNRE).

Editor / Curator -
Drone Stock Review, Cameron Chell
Drones

Draganfly (DPRO) the Tesla of Drones, Locked and Loaded.

Editor / Curator -
Featured

Hapbee (HAPB) Expands Leadership Team to Support Aggressive Growth Strategy

Editor / Curator -
1...567...19Page 6 of 19

Latest article

Gold prices plunge in biggest one-day drop in years. Is the record rally over?...

All News Editor / Curator -
Easing anxieties over Trump’s tariff policies and the Fed chair’s fate spark gold’s worst daily decline since 2021 Gold...

Gold Price Sets New Intraday Record Above $3,500 (WSJ)

All News Editor / Curator -
Gold hit another record Tuesday, then faded a bit in afternoon trading. The most actively traded futures contracts surged...

Gold Surges to a Record Above $3,400 as Trump threatens Fed Independence (CNBC)

All News Editor / Curator -
Gold prices broke $3,400 on Monday, hitting a new record as President Donald Trump’s threats against the...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.